Q03164 (KMT2A_HUMAN) Homo sapiens (Human)
Histone-lysine N-methyltransferase 2A UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
MLL cleavage product N320 1-2718; PRO_0000390949
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of MLL1 PHD3-Bromo complexed with H3(1-9)K4me3 peptide |
Heteromer P68431; | 100.0 | 2×ZN; | |||
| Crystal structure of MLL1 PHD3-Bromo complexed with H3(1-9)K4me2 peptide |
Heteromer P68431; | 100 | 2×ZN; | |||
| Complex Cyp33-RRM : MLL1-PHD3 |
Heteromer Q9UNP9; | 100 | 2×ZN; | |||
| Trimolecular complex Cyp33-RRMdelta alpha : MLL1-PHD3 : H3K4me3 |
Heteromer Q6NXT2; Q9UNP9; | 100 | 2×ZN; | |||
| Crystal structure of human menin in complex with MLL1 and LEDGF |
Heteromer O00255; O75475; | 100 | 1×CHD; 4×GGB; 1×0BR; 4×GLV; 4×SO4; | |||
| Solution structure of LEDGF/p75 IBD in complex with MLL1 peptide (140-160) |
Heteromer O75475; | 100 | ||||
| Human menin in complex with MLL peptide |
Heteromer O00255; | 100 | 3×SO4; 2×1PE; | |||
| STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH SYNTHETIC PHOSPHONO-MLL PEPTIDE ANALOG |
Heteromer P01889; P61769; | 88.89 | 4×GOL; 1×NA; | |||
| STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH SYNTHETIC SULFO-MLL PEPTIDE ANALOG |
Heteromer P01889; P61769; | 100 | 3×GOL; | |||
| STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE AND BOUND GLYCEROL |
Heteromer P01889; P61769; | 100 | 7×GOL; | |||
| STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PEPTIDE AND BOUND GLYCEROL |
Heteromer P01889; P61769; | 100 | 5×GOL; | |||
| CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE |
Heteromer P01889; P61769; | 100 | 1×GLC; | |||
| CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PEPTIDE |
Heteromer P01889; P61769; | 100 | 2×GOL; 1×CL; 1×NA; | |||
| STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE, CUBIC CRYSTAL FORM |
Heteromer P01889; P61769; | 100 | 1×12P; 1×PE8; 2×PGE; 1×PEG; 1×PG4; 1×ACT; 1×1PE; | |||
| Crystal structure of human menin in complex with MLL1 |
Heteromer O00255; | 100 | ||||
| Crystal structure of MLL1 PHD3-Bromo in the free form | monomer | 100.0 | 2×ZN; | |||
| Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone… | monomer | 95.83 | 2×ZN; | |||
| The solution structure of the PHD3 finger of MLL | monomer | 100 | 2×ZN; | |||
| Solution structure of MLL CXXC domain in complex with palindromic CPG DNA | monomer | 100 | 2×ZN; | |||
| Solution structure of MLL CXXC domain | monomer | 100 | 2×ZN; | |||
| Crystal structure of MLL CXXC domain in complex with a CpG DNA | monomer | 100 | 2×ZN; | |||
| Solution structure of the LEDGF/p75 IBD - MLL1 (aa 111-160) complex | monomer | 100 | ||||
| Solution structure of MLL1 PHD3-Cyp33 RRM chimeric protein | monomer | 100 | ||||
| Solution structure of MLL-IBD complex | monomer | 100.0 | ||||
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3lqh.1.A | monomer | 0.67 | 2×ZN; | 100.00 | ||
| 2ri7.1.A | monomer | 0.55 | 2×ZN; | 20.12 | ||
MLL cleavage product C180 2719-3969; PRO_0000390950
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode01 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3; | 98.88 | ||||
| Cryo-EM structure of human MLL1-ubNCP complex (3.2 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q9UBL3; | 100.0 | 1×SAH; 1×ZN; 1×LYS; 1×GLN; | |||
| Cryo-EM structure of human MLL1-NCP complex, binding mode1 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3; | 100.0 | 1×SAH; 1×ZN; 1×LYS; 1×GLN; | |||
| Cryo-EM structure of human MLL1-ubNCP complex (4.0 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q9UBL3; | 100.0 | 1×SAH; 1×ZN; | |||
| Cryo-EM structure of human MLL1-NCP complex, binding mode2 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3; | 100.0 | 1×SAH; 1×ZN; | |||
| Ternary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenos… |
Heteromer P68433; | 100 | 1×ZN; 1×SAH; 2×GOL; | |||
| Crystal structure of the MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L complex |
Heteromer Q15291; Q9UBL3; | 98.09 | 1×SAH; 1×ZN; | |||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me1 peptide |
Heteromer Q15291; Q6NXT2; Q9UBL3; | 98.09 | 1×SAH; 1×ZN; | |||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me2 peptide |
Heteromer Q15291; Q6NXT2; Q9UBL3; | 98.09 | 1×SAH; 1×ZN; | |||
| The crystal structure of MLL1 (N3861I/Q3867L) in complex with RbBP5 and Ash2L |
Heteromer Q15291; Q9UBL3; | 98.69 | 1×SAH; 1×ZN; | |||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me0 peptide |
Heteromer Q15291; Q6NXT2; Q9UBL3; | 98.08 | 1×SAH; 1×ZN; | |||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3; | 98.69 | ||||
| Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode02 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3; | 98.69 | ||||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3; | 98.65 | ||||
| Cryo-EM structure of MLL1 in complex with RbBP5 and WDR5 bound to the nucleosome |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; | 98.69 | 1×SAH; 1×ZN; | |||
| Cryo-EM structure of MLL1 core complex bound to the nucleosome |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9C005; Q9UBL3; | 98.69 | 2×SAH; 2×ZN; | |||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3; | 98.68 | ||||
| Crystal structure of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Aden… |
Heteromer Q53HL2; | 94.36 | 1×ZN; 1×SAH; | |||
| Structural basis for cooperative transcription factor binding to the CBP coactivator |
Heteromer P06876; P45481; | 93.55 | ||||
| Crystal structure of the KIX domain of CBP in complex with a MLL/c-Myb chimera |
Heteromer P01103; Q92793; | 100 | 2×GOL; 7×CL; | |||
| Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic c… |
Heteromer Q92793; | 94.74 | ||||
| Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic c… |
Heteromer P16220; Q92793; | 94.74 | ||||
| X-ray structure of WDR5-MLL1 Win motif peptide binary complex |
Heteromer P61964; | 100 | ||||
| Structure of WDR5 bound to MLL1 peptide |
Heteromer P61964; | 100 | 3×SO4; | |||
| Structural and biochemical insights into MLL1 core complex assembly and regulation. |
Heteromer P61964; Q15291; | 88.89 | ||||
| Structural basis of WDR5-MLL interaction |
Heteromer P61964; | 100 | 2×SO4; | |||
| Binary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenosy… | monomer | 100.0 | 1×ZN; 1×SAH; | |||
| The Crystal Structure of MLL1 SET domain with N3816I/Q3867L mutation | monomer | 98.65 | 1×ZN; 1×SAH; | |||
| MLL1 SET N3861I/Q3867L bound to inhibitor 18 (TC-5153) | monomer | 98.66 | 1×ZN; 1×Q2V; | |||
| MLL1 SET N3861I/Q3867L bound to inhibitor 12 (TC-5140) | monomer | 98.66 | 1×ZN; 1×Q2P; | |||
| MLL1 SET N3861I/Q3867L bound to inhibitor 14 (TC-5139) | monomer | 98.64 | 1×Q34; 1×ZN; | |||
| MLL1 SET N3861I/Q3867L bound to inhibitor 16 (TC-5109) | monomer | 98.65 | 1×ZN; 1×Q2M; | |||
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5jlb.1.A | monomer | 0.60 | 1×ZN; | 32.03 | ||
| 6kiu.1.K | monomer | 0.59 | 1×ZN; 1×LYS; | 100.00 | ||
8 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3lqh.1.A | monomer | 0.67 | 2×ZN; | 100.00 | ||
| Isoform 2 | 5jlb.1.A | monomer | 0.60 | 1×ZN; | 32.03 | ||
| Isoform 2 | 6kiu.1.K | monomer | 0.59 | 1×ZN; 1×LYS; | 100.00 | ||
| Isoform 2 | 2ri7.1.A | monomer | 0.56 | 2×ZN; | 20.61 | ||
| Isoform 3 | 3lqh.1.A | monomer | 0.66 | 2×ZN; | 100.00 | ||
| Isoform 3 | 5jle.1.A | monomer | 0.59 | 1×ZN; | 32.03 | ||
| Isoform 3 | 6kiu.1.K | monomer | 0.58 | 1×ZN; 1×LYS; | 100.00 | ||
| Isoform 3 | 6aze.1.A | monomer | 0.53 | 1×ZN; | 21.95 | ||